TDNDOMS: Dry Needling in Subjects With Delayed Onset Muscle Soreness

Sponsor
Bradley University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03876080
Collaborator
(none)
36
1
2
45
0.8

Study Details

Study Description

Brief Summary

Investigation of the biomechanical response in delayed onset muscle soreness using dry needling vs. sham

Condition or Disease Intervention/Treatment Phase
  • Other: Dry needling
  • Other: Sham needling
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Biomechanical Response to Dry Needling in Subjects With Delayed Onset Muscle Soreness: a Double Blind Randomized Control Trial
Actual Study Start Date :
Mar 30, 2019
Anticipated Primary Completion Date :
Dec 30, 2022
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dry needling

Dry needling intervention to the gastrocnemius muscle trigger point

Other: Dry needling
The use of a solid filiform needle to treat trigger points

Sham Comparator: Sham needling

Sham dry needling intervention to the gastrocnemius muscle trigger point

Other: Sham needling
Simulated needling

Outcome Measures

Primary Outcome Measures

  1. Change in Biomechanical stiffness (N/m) using MyotonPRO [baseline, immediately after intervention, 24 hours after intervention]

    Measuring Biomechanical stiffness ( N/m) change at the following time frames

Secondary Outcome Measures

  1. Change in Pressure pain threshold using pressure algometry [baseline, immediately after intervention, 24 hours after intervention]

    Measuring Pressure pain threshold change at the following time frames

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • The participants of the study will be any healthy male or female between

  • age of 18 to 35

  • able and willing to perform an exercise protocol using the gastrocnemius muscle

  • willing to receive either sham or dry needling intervention

Exclusion Criteria:
  • current muscular pain

  • prior trigger point therapy in the past 6 months

  • medications that affect muscle function

  • injury in the past 6 months

  • any health condition that prevents exercising

  • recent surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bradley University Peoria Illinois United States 61625

Sponsors and Collaborators

  • Bradley University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joseph Kelly, Assistant Professor, Bradley University
ClinicalTrials.gov Identifier:
NCT03876080
Other Study ID Numbers:
  • CUHSR 71-18
First Posted:
Mar 15, 2019
Last Update Posted:
Mar 10, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2022